Physician
Obstetrics & Gynecology
Dr. Patricia Braly, MD
|
|
Give Review
Patricia Braly works in the field of Obstetrics & Gynecology. She attended University of California Irvine School of Medicine. University of California Irvine School of Medicine is ranked 45/62 in Research/PrimaryCare. She over the years received 6 awards: "America's Top Doctors", "America's Top Doctors for Cancer", "CMS Meaningful Use Stage 1 Certification", "Fellow (FACOG)", "Fellow (FACS)" and "Super Doctor". Patricia Braly has written publications. She has 62 publications published with PubMed. The lastest publication is: 'Phase I and pharmacokinetic study of intraperitoneal topotecan.' Patricia Braly accepts Medicare payments and is registered with Medicare.gov.
Publications
- A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma.
- Prevalence of human papillomavirus genotypes in women from three clinical settings.
- Combined intraperitoneal and intravenous chemotherapy for women with optimally debulked ovarian cancer: results from an intergroup phase II trial.
- ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trial.
- The Immune adjuvant properties of front-line carboplatin-paclitaxel: a randomized phase 2 study of alternative schedules of intravenous oregovomab chemoimmunotherapy i...
- A pilot study to evaluate the safety and clinical outcomes of once-weekly epoetin alfa 80,000 u in anemic patients with cancer receiving chemotherapy.
- The significance of fetal heart rate reactivity with a positive oxytocin challenge test.
- A simple method of fetal and neonatal heart rate beat-to-beat variability quantitation: preliminary report.
- The use of amniocentesis in patients with premature rupture of membranes.
- Intraperitoneal cisplatin-based chemotherapy for ovarian carcinoma.
- High doses of prochlorperazine for cisplatin-induced emesis. A prospective, random, dose-response study.
- Technical aspects of intraperitoneal chemotherapy in abdominal carcinomatosis.
- Isolation of kinetoplast-mitochondrial complexes from Leishmania tarentolae.
- Synchronization of Leishmania tarentolae by hydroxyurea.
- Fetal heart rate patterns in infants in whom necrotizing enterocolitis develops: a preliminary report.
- Randomized placebo-controlled multicenter evaluation of diethyldithiocarbamate for chemoprotection against cisplatin-induced toxicities.
- Immediate vaginal reconstruction following resection for malignancy using the gluteal thigh flap.
- Phase I trial of cisplatin in combination with glutathione.
- A phase I and pharmacokinetic study of intraperitoneal carboplatin and etoposide.
- High-dose biweekly intraperitoneal cisplatin: an effective way to increase cisplatin dose intensity.
- Single-agent trabectedin as second-line therapy of persistent or recurrent endometrial cancer: results of a multicenter phase II study.
- Solitary recurrent metastasis of epithelial ovarian cancer in the spleen.
- Dose intensification of cisplatin chemotherapy through biweekly administration.
- DNA content and S-phase fraction in epithelial ovarian cancer: what information do they really add?
- Preventing cervical cancer.
- Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term f...
- Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously treated patients with advanced ovarian cancer: long-term follow-up.
- Distribution of human papillomavirus type 16 variants in human immunodeficiency virus type 1-positive and -negative women.
- Phase I and pharmacokinetic study of intraperitoneal ormaplatin.
- A comparison of intravenous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancer.
- Intraperitoneal administration of cisplatin and 5-fluorouracil in residual ovarian cancer: a Phase II Gynecologic Oncology Group trial.
- Response of human adenocarcinoma to chemotherapy: as sole agents and in combination with sodium ibuprofen.
- Flow cytometry as a prognostic factor in endometrial cancer--what does it add?
- Prospective randomized study of corticosteroids in the management of premature rupture of the membranes and the premature gestation.
- Incidence of premature delivery following the oxytocin challenge test.
- Depressed natural killer cell activity in tumor-bearing rats: effect of immunotherapy and cytoreductive chemotherapy.
- Accurate predictions of tumor growth in vivo: the subrenal capsule implant site.
- The subrenal capsule tumor implant assay as a predictor of clinical response to chemotherapy: 3 years of experience.
- Complications of pelvic exenteration.
- Semipermanent right atrial catheter in gynecologic cancer patients.
- Treatment of cutaneous vulvar lesions with skinning vulvectomy.
- Accurate laboratory predictions of the clinical response of patients with advanced ovarian cancer to treatment with cyclophosphamide, doxorubicin, and cisplatin.
- Quantitative nuclear DNA analysis of human ovarian adenocarcinoma: compared before and after chemotherapy and correlated with clinical response.
- Circadian gating of S phase in human ovarian cancer.
- Tumor DNA content as a prognostic feature in advanced epithelial ovarian carcinoma.
- Circadian and ultradian rhythms of proliferation in human ovarian cancer.
- Indiana pouch continent urinary reservoir in patients with previous pelvic irradiation.
- Prevalence of simple adnexal cysts in postmenopausal women.
- Phase I and pharmacokinetic trial of intraperitoneal etoposide in combination with the multidrug-resistance-modulating agent dipyridamole.
- Circadian and ultradian cytokinetic rhythms of spontaneous human cancer.
- Endometrial thickness after menopause: effect of hormone replacement.
- The current status of flow cytometry in gynecologic oncology.
- Introducing evidence-based medicine into a department of obstetrics and gynecology.
- Use of ileocecal continent urinary reservoir in patients with previous pelvic irradiation.
- Profiles of women age 30-39 and age less than 30 with epithelial ovarian cancer.
- A simplified approach to superficial inguinal dissection with sparing of the saphenous vein in patients with carcinoma of the vulva.
- Flow cytometric evaluation of ovarian cancer.
- Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic onc...
- Phase I and pharmacokinetic study of intraperitoneal topotecan.
- Comparative analysis of methods for collection and measurement of cytokines and immunoglobulins in cervical and vaginal secretions of HIV and HPV infected women.
- A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimens.
Schools
University of California At Irvine California College of Medicine amp Surgery
Procedures Preformed
- Abdominal Hysterectomy With Robotic Assistance
- Colpopexy
- Colpopexy With Robotic Assistance
- Colporrhaphy
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACOG)
- Fellow (FACS)
- Super Doctor
Education
-
University of California Irvine -
University of California Irvine School of Medicine
Hospital
-
Ochsner Baptist
Drug Facts
| NPI NUMBER | 1457316283 | |
| NPPES Provider LastName | BRALY | |
| NPPES Provider FirstName | PATRICIA | |
| NPPES Provider ZIPCode | 70433 | |
| NPPES Provider State | LA | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 596.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 32.0 | |
| Percent Opioid Claims | 5.37 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1457316283 |
| Last Name Of The Provider | BRALY |
| First Name Of The Provider | PATRICIA |
| View All |
Similar Doctors
|
Dr. Peter Y. Lu, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Jessica Rinaldo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Walter A. Scheuermann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary L. Cherry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Glenn P. Palmisano, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William Landry, MD
This Doctor is OpenDoctor Recommended.
|